Table 2. Number and percentage of deaths, mean coefficient per 100,000 inhabitants, and trend of oral and pharyngeal cancer mortality rates according to anatomical site. Brazil, 2002–2013.
ICD-10 | Deaths | Average Coefficienta | APCb | 95%CIc | Interpretation | |
---|---|---|---|---|---|---|
n | % | |||||
Anatomical site | ||||||
C00 – Lip | 589 | 0.8 | < 0.1 | -0.1 | -7.5–7.8 | Stable |
C01 – Base of tongue | 4,491 | 6.0 | 0.2 | 2.4 | -0.9–5.9 | Stable |
C02 – Other and unspecified parts of tongue | 10,326 | 13.9 | 0.5 | -0.4 | -2.5–1.8 | Stable |
C03 – Gum | 473 | 0.6 | < 0.1 | -0.5 | -5.1–4.3 | Stable |
C04 – Floor of mouth | 2,040 | 2.7 | 0.1 | 2.7 | -0.3–5.8 | Stable |
C05 – Palate | 2,650 | 3.6 | 0.1 | 0.7 | -2.2–3.6 | Stable |
C06 – Other and unspecified parts of mouth | 11,683 | 15.7 | 0.6 | -2.5 | -5.3–0.5 | Stable |
C07 – Parotid gland | 2,489 | 3.4 | 0.1 | -1.6 | -6.3–3.3 | Stable |
C08 – Other and unspecified major salivary glands | 793 | 1.1 | < 0.1 | -5.0 | -9.5– -0. | Decrease |
C09 – Tonsil | 1,705 | 2.3 | 0.1 | -6.7 | -9.4– -3. | Decrease |
C10 – Oropharynx | 17,292 | 0.2 | 0.9 | -0.7 | -3.4–2.0 | Stable |
C11 – Nasopharynx | 3,181 | 4.3 | 0.2 | -0.7 | -2.9–1.6 | Stable |
C12 – Pyriform Sinus | 787 | 1.1 | < 0.1 | -3.2 | -8.4–2.4 | Stable |
C13 – Hypopharynx | 4,789 | 6.4 | 0.3 | -5.9 | -9.5– -2. | Decrease |
C14 – Other and ill-defined sites in the lip oral cavity, and pharynx | 11,054 | 14.9 | 0.6 | -3.8 | -6.4– -1. | Decrease |
Grouped sites | ||||||
C01 + C02 – Tongue | 14,817 | 0.8 | 0.4 | -1.2–2.0 | Stable | |
C07 + C08 – Parotid gland and other and unspecified major salivary glands | 3,282 | 0.2 | -2.8 | -6.0–0.4 | Stable | |
C09 + C10 – Tonsil and oropharynx | 18,997 | 1.0 | -1.3 | -3.6–1.1 | Stable |
Rates standardized by the world population, WHO 13 .
Annual percentage change.
Confidence interval of the APC.